Carrier screening in health-care workers treating patients with MDR strains

Mark Loeb

Should the health-care personnel treating a patient infected with a multidrug-resistant strain undergo carrier screening? If yes, when should the tests be performed: on a regular basis in all staff or only in case of exposure?

Mark Loeb: There is really no evidence at this point that there is any real benefit to screening doctors, for example, who have been exposed to a patient, especially if they are using adequate infection control precautions.

See also

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.